Embark offers the most comprehensive, most accurate dog DNA test on the market. An Embark dog DNA test gives pet owners information about their dog’s breed, ancestry, health, and more — all with just a simple cheek swab. The company uses twice as much genetic information as any other test available and features the world’s only canine DNA relative finder. Pet owners can use Embark to test for over 210 genetic health conditions, so they can make the best choices for their dog. Launched by two brothers, Embark is an official research partner with Cornell University College of Veterinary Medicine and has a mission to end preventable disease in dogs.

Third Kind Venture Capital

Section 32 F-Prime Capital

FJ Labs

Slow Ventures

Freestyle Capital

Anne Wojcicki

SoftBank Vision Fund

Embark Veterinary

Embark Veterinary is heading to Orlando for VMX 2024! Come on over and meet the team at booth #1978 and be sure to check out our CE session: Let's Get Clinical: Real world management of common testable canine genetic conditions on Monday, January 15th at 5:45 PM.

🐶 🧬 We're excited to share that Embark Veterinary dog DNA tests, including the Embark for Veterinarians 10-pack, the Breed ID, and the Breed + Health tests, are now available on Vetcove.com. 
✨ Buying dog DNA tests has never been easier! ✨ 
✅ Check it out: https://lnkd.in/eZx97t4S 

We’re excited to announce that Amish Desai, who joined Embark in 2022 as chief financial officer, is stepping into a new role as Embark’s CEO! 🌟 With a focus on our core DNA offerings as well as strategic expansions into new channels and products, Amish is dedicated to helping dog owners form stronger bonds with their best friends.

Learn more here:
https://lnkd.in/eWwUqVt6

Viewport Meta

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

DNSSEC

Content Delivery Network

Cloudflare CDN

Person Schema

Cloudflare

Chief Operating Officer

Adam Medros

Board Member

Ryan Boyko

Chief Financial Officer

Steve Boulanger

VP, Brand Strategy & Insights

Allyson Schultz

Vice President of Sales

Laura Vickers, MBA

VP of People

Tali Ronen

Director of Research and Development, Scientific Product

Aaron Sams

Director, Business Development

Adam Tracy

Art Director

Ashley Sebastian

Sr. Director of Product Management

Chuck Burt

Matt Salzberg

Spencer Wells

Alex Stavros

Founder & CEO

Adam Boyko

Co-founder & Chief Science Officer

Board Member & Co-Founder

Matt Barton

Founding Engineer, CTO, Director of Scientific Engineering

Amish Desai

Chief Executive Officer

Greg Herburger

Sr. Growth Marketing Manager, CRM

Vice President of People

Northeastern US Companies With Less Than $50M in Revenue (Top 10K)

Freestyle Capital Portfolio Companies

Boston Companies With Less Than $50M in Revenue

Health Care Early Stage Companies With More Than 50 Employees

Embark offers dog DNA testing that ends preventable diseases in dogs. It was founded by top experts in genomics, computational biology, and software design to sell an industry-leading dog DNA test. They use a clinical-grade CLIA-certified SNP chip to provide the most accurate and comprehensive results (200,000+ genetic markers) available on the market. 

Their data contributes to proprietary genetics research that will help dog owners optimize nutrition, exercise, allergies, and prevent a variety of heritable conditions. Their technological advantage, intellectual capital, and research-focus enable them to push canine health toward our shared vision of preventative veterinary care.

Series B - Embark

Series A - Embark

Founder Collective

Seed Round - Embark

Computer and Software Services and Scientific Services

Boston

Massachusetts

United States

North America

Embark

Genetic Testing Delivers Startup Hits And Misses

Embark Teams Up with the CFL to Score Big on Education

Embark Goes Live With Dayshape as the Consulting Firm Continues to Disrupt the Professional Services Industry

Embark Announces Rebrand, Declares 'Consulting is Dead' in Obituary Campaign

Dallas-Based Embark Declares ‘Consulting is Dead,’ Will Send Mini‑Coffins to CFOs Nationwide

Old Dogs Can Inspire New Business Models

Dallas’ Embark Adds Former Global CEO of Deloitte and Managing Director of CoVenture to Its Board

Business Advisory Firm Embark Announces Record $149 Million Revenue Year

Embark Announces Leadership Transition: Amish Desai Appointed as Chief Executive Officer and Ryan Boyko to serve as Board Member

Embark opens fintech skills school in Dundee

Canada

Germany

Europe

India

Asia

Taiwan

HTML5

Facebook Comments

Disqus

Google Fonts

Yotpo

jQuery

Google Maps API

Google Analytics

Google Cloud Translation API

Office 365

Embark is a canine genomics and biotechnology company that offers dog DNA testing services to consumers, breeders, and veterinarians. Their goal is to help pet owners better understand their dog's health and risk for heritable diseases, and to advance canine DNA research.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	f3872dcb
crunchbase profile	general	Nov 25, 2024 11:37 AM	d970dde3
li profile	general	Jan 29, 2024 10:43 AM	f288ed89
translate crunchbase fundingrounds	general	Nov 25, 2024 2:15 PM	993e0dca
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:EMBARKVET

Embark